Drug
Beam 201
Beam 201: highest development phase Phase 1/2, developed by Beam Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Beam Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| BEAM-201 NCT05885464 | Phase 1/2 | Lymphoblastic Lymphoma |
Latest
No recent events.
Follow Beam 201 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.